CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 227 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $414,046,272 | +21.7% | 15,197,147 | -0.6% | 0.01% | +33.3% |
| Q2 2023 | $340,175,403 | -2.6% | 15,288,782 | -5.2% | 0.01% | -10.0% |
| Q1 2023 | $349,350,134 | +5.2% | 16,128,815 | -1.3% | 0.01% | 0.0% |
| Q4 2022 | $332,015,349 | -20.0% | 16,347,383 | +1.0% | 0.01% | -28.6% |
| Q3 2022 | $415,037,000 | +12.8% | 16,187,049 | +4.7% | 0.01% | +16.7% |
| Q2 2022 | $367,820,000 | +5.9% | 15,467,633 | +0.3% | 0.01% | +33.3% |
| Q1 2022 | $347,366,000 | +16.6% | 15,424,767 | +2.5% | 0.01% | +12.5% |
| Q4 2021 | $297,950,000 | -2.9% | 15,047,993 | -3.5% | 0.01% | -11.1% |
| Q3 2021 | $306,885,000 | -10.7% | 15,593,876 | -0.2% | 0.01% | -10.0% |
| Q2 2021 | $343,651,000 | -10.7% | 15,620,518 | -3.4% | 0.01% | -9.1% |
| Q1 2021 | $384,714,000 | -5.4% | 16,171,231 | +4.0% | 0.01% | -15.4% |
| Q4 2020 | $406,698,000 | +55.0% | 15,546,524 | +3.1% | 0.01% | +30.0% |
| Q3 2020 | $262,388,000 | -1.8% | 15,075,424 | -5.1% | 0.01% | -9.1% |
| Q2 2020 | $267,181,000 | +47.4% | 15,884,743 | +4.2% | 0.01% | +22.2% |
| Q1 2020 | $181,259,000 | -5.9% | 15,244,767 | -4.2% | 0.01% | +28.6% |
| Q4 2019 | $192,633,000 | -12.3% | 15,920,086 | +2.5% | 0.01% | -22.2% |
| Q3 2019 | $219,625,000 | +25.2% | 15,537,529 | -1.2% | 0.01% | +12.5% |
| Q2 2019 | $175,365,000 | -5.8% | 15,727,792 | -0.8% | 0.01% | 0.0% |
| Q1 2019 | $186,072,000 | -10.3% | 15,849,366 | +2.1% | 0.01% | -20.0% |
| Q4 2018 | $207,477,000 | -6.0% | 15,529,665 | -1.4% | 0.01% | 0.0% |
| Q3 2018 | $220,750,000 | -1.1% | 15,745,397 | +10.9% | 0.01% | 0.0% |
| Q2 2018 | $223,220,000 | +5.1% | 14,199,726 | +10.0% | 0.01% | 0.0% |
| Q1 2018 | $212,288,000 | +3.1% | 12,905,164 | +13.2% | 0.01% | 0.0% |
| Q4 2017 | $205,871,000 | +37.5% | 11,399,287 | +47.0% | 0.01% | +25.0% |
| Q3 2017 | $149,703,000 | +69.3% | 7,756,550 | +3.5% | 0.01% | +60.0% |
| Q2 2017 | $88,414,000 | +16.9% | 7,492,585 | +8.6% | 0.01% | +25.0% |
| Q1 2017 | $75,600,000 | +40112.8% | 6,897,752 | +26495.3% | 0.00% | – |
| Q4 2016 | $188,000 | +5.6% | 25,936 | -5.4% | 0.00% | – |
| Q3 2016 | $178,000 | +17.9% | 27,418 | -1.0% | 0.00% | – |
| Q2 2016 | $151,000 | +843.8% | 27,699 | +709.7% | 0.00% | – |
| Q1 2016 | $16,000 | +166.7% | 3,421 | +176.3% | 0.00% | – |
| Q4 2015 | $6,000 | +20.0% | 1,238 | 0.0% | 0.00% | – |
| Q3 2015 | $5,000 | -28.6% | 1,238 | 0.0% | 0.00% | – |
| Q2 2015 | $7,000 | -30.0% | 1,238 | -28.7% | 0.00% | – |
| Q1 2015 | $10,000 | +100.0% | 1,737 | 0.0% | 0.00% | – |
| Q4 2014 | $5,000 | 0.0% | 1,737 | 0.0% | 0.00% | – |
| Q3 2014 | $5,000 | -28.6% | 1,737 | +9.2% | 0.00% | – |
| Q1 2014 | $7,000 | +600.0% | 1,591 | +97.6% | 0.00% | – |
| Q3 2013 | $1,000 | 0.0% | 805 | 0.0% | 0.00% | – |
| Q2 2013 | $1,000 | – | 805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |